nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—AKR1C3—Bimatoprost—glaucoma	0.4	0.82	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—glaucoma	0.302	1	CbGaD
Medroxyprogesterone Acetate—CYP2C9—Diclofenamide—glaucoma	0.0147	0.0302	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Dorzolamide—glaucoma	0.0142	0.0291	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Methazolamide—glaucoma	0.0127	0.026	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Pilocarpine—glaucoma	0.0109	0.0223	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Brinzolamide—glaucoma	0.00855	0.0175	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Dorzolamide—glaucoma	0.00826	0.0169	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Methazolamide—glaucoma	0.00736	0.0151	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Acetazolamide—glaucoma	0.00589	0.0121	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Clonidine—glaucoma	0.00532	0.0109	CbGbCtD
Medroxyprogesterone Acetate—Cyproterone acetate—NR3C1—glaucoma	0.000565	0.142	CrCbGaD
Medroxyprogesterone Acetate—Prednicarbate—NR3C1—glaucoma	0.000364	0.0912	CrCbGaD
Medroxyprogesterone Acetate—Medrysone—NR3C1—glaucoma	0.000305	0.0765	CrCbGaD
Medroxyprogesterone Acetate—Flurandrenolide—NR3C1—glaucoma	0.000294	0.0737	CrCbGaD
Medroxyprogesterone Acetate—Hydrocortamate—NR3C1—glaucoma	0.000285	0.0713	CrCbGaD
Medroxyprogesterone Acetate—Cortisone acetate—NR3C1—glaucoma	0.00028	0.0702	CrCbGaD
Medroxyprogesterone Acetate—Megestrol acetate—NR3C1—glaucoma	0.00027	0.0677	CrCbGaD
Medroxyprogesterone Acetate—Fludrocortisone—NR3C1—glaucoma	0.000222	0.0556	CrCbGaD
Medroxyprogesterone Acetate—Fluorometholone—NR3C1—glaucoma	0.000214	0.0536	CrCbGaD
Medroxyprogesterone Acetate—Methylprednisolone—NR3C1—glaucoma	0.000207	0.0518	CrCbGaD
Medroxyprogesterone Acetate—Fluoxymesterone—NR3C1—glaucoma	0.000184	0.0459	CrCbGaD
Medroxyprogesterone Acetate—Spironolactone—NR3C1—glaucoma	0.000168	0.0421	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—CYP1B1—glaucoma	0.000153	0.0383	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—CYP1B1—glaucoma	0.000145	0.0362	CrCbGaD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—glaucoma	0.000134	0.0335	CrCbGaD
Medroxyprogesterone Acetate—Hydrocortisone—NR3C1—glaucoma	0.000112	0.0279	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—NR3C1—glaucoma	9.09e-05	0.0228	CrCbGaD
Medroxyprogesterone Acetate—Malaise—Clonidine—glaucoma	8.17e-05	0.000483	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Betaxolol—glaucoma	8.17e-05	0.000482	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Pilocarpine—glaucoma	8.15e-05	0.000481	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Betaxolol—glaucoma	8.13e-05	0.00048	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Clonidine—glaucoma	8.13e-05	0.00048	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Dorzolamide—glaucoma	8.08e-05	0.000477	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Pilocarpine—glaucoma	8.05e-05	0.000475	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Travoprost—glaucoma	8.04e-05	0.000475	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Dorzolamide—glaucoma	8.02e-05	0.000473	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Betaxolol—glaucoma	8.01e-05	0.000473	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Clonidine—glaucoma	8.01e-05	0.000473	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Pilocarpine—glaucoma	8e-05	0.000472	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Travoprost—glaucoma	7.98e-05	0.000471	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Clonidine—glaucoma	7.97e-05	0.00047	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Brinzolamide—glaucoma	7.94e-05	0.000469	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Betaxolol—glaucoma	7.94e-05	0.000469	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Pilocarpine—glaucoma	7.92e-05	0.000468	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Timolol—glaucoma	7.91e-05	0.000467	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Apraclonidine—glaucoma	7.91e-05	0.000467	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Betaxolol—glaucoma	7.89e-05	0.000466	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Betaxolol—glaucoma	7.89e-05	0.000466	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Dorzolamide—glaucoma	7.79e-05	0.00046	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Timolol—glaucoma	7.78e-05	0.000459	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Dorzolamide—glaucoma	7.75e-05	0.000457	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Dorzolamide—glaucoma	7.75e-05	0.000457	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Betaxolol—glaucoma	7.74e-05	0.000457	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Timolol—glaucoma	7.74e-05	0.000457	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Betaxolol—glaucoma	7.73e-05	0.000456	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Clonidine—glaucoma	7.72e-05	0.000456	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Clonidine—glaucoma	7.72e-05	0.000456	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Travoprost—glaucoma	7.72e-05	0.000456	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Clonidine—glaucoma	7.69e-05	0.000454	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Acetazolamide—glaucoma	7.67e-05	0.000453	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Bimatoprost—glaucoma	7.66e-05	0.000453	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Betaxolol—glaucoma	7.66e-05	0.000452	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	7.66e-05	0.000452	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Brinzolamide—glaucoma	7.66e-05	0.000452	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Pilocarpine—glaucoma	7.63e-05	0.000451	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Clonidine—glaucoma	7.62e-05	0.00045	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Apraclonidine—glaucoma	7.6e-05	0.000449	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Betaxolol—glaucoma	7.59e-05	0.000448	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Pilocarpine—glaucoma	7.57e-05	0.000447	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Brimonidine—glaucoma	7.56e-05	0.000446	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Clonidine—glaucoma	7.55e-05	0.000446	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Timolol—glaucoma	7.54e-05	0.000445	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Apraclonidine—glaucoma	7.53e-05	0.000445	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Apraclonidine—glaucoma	7.49e-05	0.000442	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Clonidine—glaucoma	7.46e-05	0.00044	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Clonidine—glaucoma	7.4e-05	0.000437	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Betaxolol—glaucoma	7.39e-05	0.000436	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Brimonidine—glaucoma	7.36e-05	0.000435	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Clonidine—glaucoma	7.35e-05	0.000434	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Pilocarpine—glaucoma	7.32e-05	0.000432	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Pilocarpine—glaucoma	7.32e-05	0.000432	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Betaxolol—glaucoma	7.32e-05	0.000432	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Acetazolamide—glaucoma	7.32e-05	0.000432	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Bimatoprost—glaucoma	7.31e-05	0.000431	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Bimatoprost—glaucoma	7.3e-05	0.000431	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Timolol—glaucoma	7.29e-05	0.000431	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Betaxolol—glaucoma	7.29e-05	0.000431	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Clonidine—glaucoma	7.28e-05	0.00043	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Timolol—glaucoma	7.28e-05	0.00043	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Brimonidine—glaucoma	7.26e-05	0.000429	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Bimatoprost—glaucoma	7.26e-05	0.000429	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Clonidine—glaucoma	7.25e-05	0.000428	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Clonidine—glaucoma	7.24e-05	0.000428	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Dorzolamide—glaucoma	7.22e-05	0.000426	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Clonidine—glaucoma	7.22e-05	0.000426	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Travoprost—glaucoma	7.19e-05	0.000425	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Clonidine—glaucoma	7.18e-05	0.000424	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Clonidine—glaucoma	7.15e-05	0.000422	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Timolol—glaucoma	7.14e-05	0.000421	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Betaxolol—glaucoma	7.12e-05	0.00042	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Apraclonidine—glaucoma	7.1e-05	0.000419	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Brinzolamide—glaucoma	7.1e-05	0.000419	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Betaxolol—glaucoma	7.09e-05	0.000419	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Betaxolol—glaucoma	7.08e-05	0.000418	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Acetazolamide—glaucoma	7.07e-05	0.000418	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	7.06e-05	0.00191	CbGpPWpGaD
Medroxyprogesterone Acetate—Anorexia—Clonidine—glaucoma	7.05e-05	0.000416	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—NOS3—glaucoma	7.05e-05	0.0019	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Dorzolamide—glaucoma	7.03e-05	0.000415	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Travoprost—glaucoma	7e-05	0.000413	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—LRP12—glaucoma	6.99e-05	0.00189	CbGpPWpGaD
Medroxyprogesterone Acetate—Palpitations—Betaxolol—glaucoma	6.97e-05	0.000412	CcSEcCtD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—glaucoma	6.97e-05	0.00188	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Dorzolamide—glaucoma	6.93e-05	0.000409	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Betaxolol—glaucoma	6.93e-05	0.000409	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Timolol—glaucoma	6.92e-05	0.000409	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Brinzolamide—glaucoma	6.91e-05	0.000408	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Clonidine—glaucoma	6.91e-05	0.000408	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GSTT1—glaucoma	6.91e-05	0.00187	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Travoprost—glaucoma	6.9e-05	0.000408	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Timolol—glaucoma	6.9e-05	0.000408	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	6.89e-05	0.00186	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Bimatoprost—glaucoma	6.88e-05	0.000406	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Timolol—glaucoma	6.87e-05	0.000406	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.85e-05	0.00185	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CA1—glaucoma	6.83e-05	0.00185	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Pilocarpine—glaucoma	6.82e-05	0.000403	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Brinzolamide—glaucoma	6.82e-05	0.000403	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Acetazolamide—glaucoma	6.8e-05	0.000401	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Brimonidine—glaucoma	6.79e-05	0.000401	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Clonidine—glaucoma	6.74e-05	0.000398	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Timolol—glaucoma	6.72e-05	0.000397	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Betaxolol—glaucoma	6.72e-05	0.000397	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Betaxolol—glaucoma	6.72e-05	0.000397	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Betaxolol—glaucoma	6.72e-05	0.000397	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Dorzolamide—glaucoma	6.71e-05	0.000396	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Acetazolamide—glaucoma	6.7e-05	0.000396	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Betaxolol—glaucoma	6.69e-05	0.000395	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Clonidine—glaucoma	6.69e-05	0.000395	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Timolol—glaucoma	6.69e-05	0.000395	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Travoprost—glaucoma	6.68e-05	0.000394	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Timolol—glaucoma	6.67e-05	0.000394	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	6.67e-05	0.000394	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Pilocarpine—glaucoma	6.65e-05	0.000392	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Clonidine—glaucoma	6.64e-05	0.000392	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Betaxolol—glaucoma	6.64e-05	0.000392	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CTSA—glaucoma	6.62e-05	0.00179	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—CDKN1B—glaucoma	6.6e-05	0.00178	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspnoea—Clonidine—glaucoma	6.59e-05	0.000389	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Brinzolamide—glaucoma	6.59e-05	0.000389	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Clonidine—glaucoma	6.58e-05	0.000388	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Betaxolol—glaucoma	6.57e-05	0.000388	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—BDNF—glaucoma	6.56e-05	0.00177	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Pilocarpine—glaucoma	6.55e-05	0.000387	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Timolol—glaucoma	6.54e-05	0.000386	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—BAD—glaucoma	6.5e-05	0.00176	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—FAS—glaucoma	6.5e-05	0.00176	CbGpPWpGaD
Medroxyprogesterone Acetate—Confusional state—Betaxolol—glaucoma	6.49e-05	0.000383	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Timolol—glaucoma	6.49e-05	0.000383	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Dorzolamide—glaucoma	6.48e-05	0.000383	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Brimonidine—glaucoma	6.47e-05	0.000382	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Brimonidine—glaucoma	6.47e-05	0.000382	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Travoprost—glaucoma	6.45e-05	0.000381	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—CDKN1B—glaucoma	6.45e-05	0.00174	CbGpPWpGaD
Medroxyprogesterone Acetate—Malnutrition—Timolol—glaucoma	6.45e-05	0.000381	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Timolol—glaucoma	6.45e-05	0.000381	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Betaxolol—glaucoma	6.44e-05	0.00038	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—TNF—glaucoma	6.43e-05	0.00174	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Brimonidine—glaucoma	6.43e-05	0.00038	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Clonidine—glaucoma	6.43e-05	0.00038	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Betaxolol—glaucoma	6.4e-05	0.000378	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Clonidine—glaucoma	6.39e-05	0.000377	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Clonidine—glaucoma	6.38e-05	0.000376	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Brinzolamide—glaucoma	6.37e-05	0.000376	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—CDKN1B—glaucoma	6.35e-05	0.00172	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Acetazolamide—glaucoma	6.35e-05	0.000375	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Pilocarpine—glaucoma	6.34e-05	0.000374	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Betaxolol—glaucoma	6.34e-05	0.000374	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Timolol—glaucoma	6.33e-05	0.000373	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Clonidine—glaucoma	6.32e-05	0.000373	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Betaxolol—glaucoma	6.31e-05	0.000373	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Timolol—glaucoma	6.31e-05	0.000373	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Betaxolol—glaucoma	6.3e-05	0.000372	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL1A—glaucoma	6.3e-05	0.0017	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	6.3e-05	0.0017	CbGpPWpGaD
Medroxyprogesterone Acetate—Tachycardia—Betaxolol—glaucoma	6.28e-05	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Timolol—glaucoma	6.26e-05	0.00037	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Betaxolol—glaucoma	6.25e-05	0.000369	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CA2—glaucoma	6.25e-05	0.00169	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Dorzolamide—glaucoma	6.23e-05	0.000368	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Betaxolol—glaucoma	6.23e-05	0.000368	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	6.19e-05	0.00167	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Dorzolamide—glaucoma	6.18e-05	0.000365	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Dorzolamide—glaucoma	6.17e-05	0.000365	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Travoprost—glaucoma	6.15e-05	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Travoprost—glaucoma	6.15e-05	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—OPN4—glaucoma	6.14e-05	0.00166	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Dorzolamide—glaucoma	6.14e-05	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Betaxolol—glaucoma	6.14e-05	0.000362	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Brinzolamide—glaucoma	6.13e-05	0.000362	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Pilocarpine—glaucoma	6.12e-05	0.000362	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Travoprost—glaucoma	6.11e-05	0.000361	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.11e-05	0.00165	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.11e-05	0.00165	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Brimonidine—glaucoma	6.1e-05	0.00036	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Clonidine—glaucoma	6.1e-05	0.00036	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Brinzolamide—glaucoma	6.08e-05	0.000359	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Brinzolamide—glaucoma	6.07e-05	0.000358	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Clonidine—glaucoma	6.05e-05	0.000357	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Brinzolamide—glaucoma	6.04e-05	0.000356	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Betaxolol—glaucoma	6.02e-05	0.000355	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—LKB1 signaling events—TP53—glaucoma	5.99e-05	0.00162	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—MMP9—glaucoma	5.97e-05	0.00161	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—CDKN1B—glaucoma	5.91e-05	0.0016	CbGpPWpGaD
Medroxyprogesterone Acetate—Angioedema—Timolol—glaucoma	5.89e-05	0.000348	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Pilocarpine—glaucoma	5.89e-05	0.000348	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—MMP9—glaucoma	5.88e-05	0.00159	CbGpPWpGaD
Medroxyprogesterone Acetate—Urticaria—Clonidine—glaucoma	5.88e-05	0.000347	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Betaxolol—glaucoma	5.87e-05	0.000346	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Clonidine—glaucoma	5.85e-05	0.000345	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Clonidine—glaucoma	5.85e-05	0.000345	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Pilocarpine—glaucoma	5.84e-05	0.000345	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Pilocarpine—glaucoma	5.83e-05	0.000344	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—NGF—glaucoma	5.83e-05	0.00157	CbGpPWpGaD
Medroxyprogesterone Acetate—Insomnia—Betaxolol—glaucoma	5.82e-05	0.000344	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Dorzolamide—glaucoma	5.82e-05	0.000344	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Pilocarpine—glaucoma	5.8e-05	0.000343	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Travoprost—glaucoma	5.8e-05	0.000342	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Timolol—glaucoma	5.79e-05	0.000342	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Betaxolol—glaucoma	5.78e-05	0.000341	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Timolol—glaucoma	5.78e-05	0.000341	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Betaxolol—glaucoma	5.74e-05	0.000339	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Brinzolamide—glaucoma	5.72e-05	0.000338	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HEYL—glaucoma	5.71e-05	0.00154	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	5.71e-05	0.00154	CbGpPWpGaD
Medroxyprogesterone Acetate—Palpitations—Timolol—glaucoma	5.7e-05	0.000336	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	5.67e-05	0.00153	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspepsia—Betaxolol—glaucoma	5.67e-05	0.000335	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Timolol—glaucoma	5.67e-05	0.000334	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—GSTT1—glaucoma	5.61e-05	0.00152	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Betaxolol—glaucoma	5.6e-05	0.00033	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.57e-05	0.00151	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.57e-05	0.00151	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Betaxolol—glaucoma	5.56e-05	0.000328	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—MMP1—glaucoma	5.55e-05	0.0015	CbGpPWpGaD
Medroxyprogesterone Acetate—Fatigue—Betaxolol—glaucoma	5.55e-05	0.000328	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PTGFR—glaucoma	5.53e-05	0.00149	CbGpPWpGaD
Medroxyprogesterone Acetate—Constipation—Betaxolol—glaucoma	5.51e-05	0.000325	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—CYP1B1—glaucoma	5.51e-05	0.00149	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—ABCA1—glaucoma	5.51e-05	0.00149	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Pilocarpine—glaucoma	5.5e-05	0.000325	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.5e-05	0.00149	CbGpPWpGaD
Medroxyprogesterone Acetate—Chest pain—Timolol—glaucoma	5.49e-05	0.000324	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Timolol—glaucoma	5.49e-05	0.000324	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Timolol—glaucoma	5.49e-05	0.000324	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Timolol—glaucoma	5.47e-05	0.000323	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	5.45e-05	0.000322	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Clonidine—glaucoma	5.45e-05	0.000322	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Timolol—glaucoma	5.42e-05	0.00032	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	5.41e-05	0.00146	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.39e-05	0.00146	CbGpPWpGaD
Medroxyprogesterone Acetate—Dry mouth—Timolol—glaucoma	5.37e-05	0.000317	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Clonidine—glaucoma	5.31e-05	0.000313	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Betaxolol—glaucoma	5.31e-05	0.000313	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Timolol—glaucoma	5.3e-05	0.000313	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Timolol—glaucoma	5.26e-05	0.000311	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Timolol—glaucoma	5.26e-05	0.000311	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Clonidine—glaucoma	5.23e-05	0.000309	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Timolol—glaucoma	5.23e-05	0.000309	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Timolol—glaucoma	5.18e-05	0.000306	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Timolol—glaucoma	5.16e-05	0.000305	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Betaxolol—glaucoma	5.12e-05	0.000302	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Timolol—glaucoma	5.11e-05	0.000302	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Betaxolol—glaucoma	5.09e-05	0.000301	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—HDAC9—glaucoma	5.09e-05	0.00138	CbGpPWpGaD
Medroxyprogesterone Acetate—Hyperhidrosis—Timolol—glaucoma	5.09e-05	0.0003	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Clonidine—glaucoma	5.06e-05	0.000299	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Timolol—glaucoma	5.01e-05	0.000296	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—BAD—glaucoma	5.01e-05	0.00135	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—BAD—glaucoma	4.98e-05	0.00135	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypotension—Timolol—glaucoma	4.92e-05	0.00029	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Clonidine—glaucoma	4.89e-05	0.000289	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	4.85e-05	0.00131	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—OPN4—glaucoma	4.85e-05	0.00131	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—CDKN2B—glaucoma	4.83e-05	0.00131	CbGpPWpGaD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Timolol—glaucoma	4.79e-05	0.000283	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Timolol—glaucoma	4.76e-05	0.000281	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Betaxolol—glaucoma	4.74e-05	0.00028	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Timolol—glaucoma	4.72e-05	0.000279	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Clonidine—glaucoma	4.7e-05	0.000278	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Timolol—glaucoma	4.69e-05	0.000277	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Timolol—glaucoma	4.68e-05	0.000276	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Clonidine—glaucoma	4.66e-05	0.000275	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Clonidine—glaucoma	4.66e-05	0.000275	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Clonidine—glaucoma	4.63e-05	0.000274	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Timolol—glaucoma	4.63e-05	0.000273	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Betaxolol—glaucoma	4.62e-05	0.000273	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Timolol—glaucoma	4.57e-05	0.00027	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—GSTT1—glaucoma	4.57e-05	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Betaxolol—glaucoma	4.56e-05	0.000269	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Timolol—glaucoma	4.54e-05	0.000268	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Timolol—glaucoma	4.54e-05	0.000268	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.52e-05	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HEYL—glaucoma	4.51e-05	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—CYP1B1—glaucoma	4.47e-05	0.00121	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	4.41e-05	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	4.41e-05	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Betaxolol—glaucoma	4.41e-05	0.00026	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GSTM1—glaucoma	4.4e-05	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—TXN—glaucoma	4.4e-05	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Clonidine—glaucoma	4.39e-05	0.000259	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PTGFR—glaucoma	4.36e-05	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—Feeling abnormal—Timolol—glaucoma	4.33e-05	0.000256	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RPTOR—glaucoma	4.33e-05	0.00117	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal pain—Timolol—glaucoma	4.3e-05	0.000254	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Betaxolol—glaucoma	4.26e-05	0.000251	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—NR3C1—glaucoma	4.24e-05	0.00115	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NCK2—glaucoma	4.19e-05	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—Urticaria—Timolol—glaucoma	4.18e-05	0.000247	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.18e-05	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—Body temperature increased—Timolol—glaucoma	4.16e-05	0.000246	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Timolol—glaucoma	4.16e-05	0.000246	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	4.15e-05	0.00112	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LRP12—glaucoma	4.1e-05	0.00111	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Betaxolol—glaucoma	4.09e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Betaxolol—glaucoma	4.06e-05	0.00024	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Betaxolol—glaucoma	4.06e-05	0.000239	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TP53—glaucoma	4.05e-05	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Betaxolol—glaucoma	4.03e-05	0.000238	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.02e-05	0.00109	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TP53—glaucoma	3.99e-05	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.98e-05	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	3.96e-05	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NARFL—glaucoma	3.93e-05	0.00106	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CA5A—glaucoma	3.93e-05	0.00106	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—MTHFR—glaucoma	3.89e-05	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Timolol—glaucoma	3.88e-05	0.000229	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Betaxolol—glaucoma	3.82e-05	0.000226	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Timolol—glaucoma	3.77e-05	0.000223	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	3.77e-05	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.75e-05	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Timolol—glaucoma	3.72e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—CDKN2B—glaucoma	3.68e-05	0.000994	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—VEGFA—glaucoma	3.67e-05	0.000991	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—CYP1B1—glaucoma	3.64e-05	0.000983	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—APOE—glaucoma	3.62e-05	0.000979	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Timolol—glaucoma	3.6e-05	0.000213	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	3.59e-05	0.00097	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—CAV1—glaucoma	3.59e-05	0.00097	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—GSTM1—glaucoma	3.57e-05	0.000966	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HDAC9—glaucoma	3.56e-05	0.000963	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	3.53e-05	0.000953	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—glaucoma	3.52e-05	0.000951	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Timolol—glaucoma	3.48e-05	0.000205	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—CDKN1B—glaucoma	3.47e-05	0.000937	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RPTOR—glaucoma	3.41e-05	0.000923	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GSTT1—glaucoma	3.41e-05	0.000922	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.4e-05	0.000919	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Timolol—glaucoma	3.34e-05	0.000197	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Timolol—glaucoma	3.32e-05	0.000196	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Timolol—glaucoma	3.31e-05	0.000196	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NCK2—glaucoma	3.31e-05	0.000894	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Timolol—glaucoma	3.3e-05	0.000195	CcSEcCtD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—NR3C1—glaucoma	3.23e-05	0.000873	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CA5A—glaucoma	3.2e-05	0.000865	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NARFL—glaucoma	3.2e-05	0.000865	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—TNF—glaucoma	3.14e-05	0.00085	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Timolol—glaucoma	3.12e-05	0.000184	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.12e-05	0.000843	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	3.05e-05	0.000824	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.01e-05	0.000814	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—GSTM1—glaucoma	2.91e-05	0.000786	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	2.9e-05	0.000784	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.89e-05	0.000781	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.87e-05	0.000775	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TP53—glaucoma	2.84e-05	0.000769	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—OPN4—glaucoma	2.84e-05	0.000769	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—CDKN2B—glaucoma	2.83e-05	0.000766	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HDAC9—glaucoma	2.81e-05	0.00076	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—CDKN2B—glaucoma	2.79e-05	0.000754	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SMO—glaucoma	2.79e-05	0.000754	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—glaucoma	2.78e-05	0.000752	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TNF—glaucoma	2.76e-05	0.000746	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.75e-05	0.000744	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CDKN2B—glaucoma	2.74e-05	0.00074	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ABCA1—glaucoma	2.72e-05	0.000735	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CYP1B1—glaucoma	2.72e-05	0.000735	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—NOS3—glaucoma	2.71e-05	0.000733	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.67e-05	0.000723	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HEYL—glaucoma	2.64e-05	0.000715	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTGFR—glaucoma	2.56e-05	0.000692	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NTRK2—glaucoma	2.55e-05	0.000689	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—NR3C1—glaucoma	2.49e-05	0.000672	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTGS2—glaucoma	2.48e-05	0.000671	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.4e-05	0.000649	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.4e-05	0.000648	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—TNF—glaucoma	2.39e-05	0.000645	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.37e-05	0.00064	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.36e-05	0.000637	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—CDKN2B—glaucoma	2.33e-05	0.000628	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MTHFR—glaucoma	2.29e-05	0.00062	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SMO—glaucoma	2.2e-05	0.000595	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TP53—glaucoma	2.19e-05	0.000592	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NGFR—glaucoma	2.19e-05	0.000591	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GSTM1—glaucoma	2.17e-05	0.000587	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—APOE—glaucoma	2.14e-05	0.000577	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CAV1—glaucoma	2.12e-05	0.000572	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CA5A—glaucoma	2.11e-05	0.00057	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NARFL—glaucoma	2.11e-05	0.00057	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NTRK1—glaucoma	2.08e-05	0.000562	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.06e-05	0.000557	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—NR3C1—glaucoma	2.04e-05	0.000551	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NTRK2—glaucoma	2.01e-05	0.000544	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RPTOR—glaucoma	2e-05	0.000542	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—BAD—glaucoma	1.99e-05	0.000538	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NCK2—glaucoma	1.94e-05	0.000524	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—MTHFR—glaucoma	1.92e-05	0.000519	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CA1—glaucoma	1.92e-05	0.000519	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.92e-05	0.000518	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CDKN2B—glaucoma	1.92e-05	0.000518	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.89e-05	0.000511	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CTSA—glaucoma	1.86e-05	0.000503	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EDN1—glaucoma	1.84e-05	0.000497	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.82e-05	0.000491	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—APOE—glaucoma	1.79e-05	0.000483	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CAV1—glaucoma	1.77e-05	0.000479	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—CDKN2B—glaucoma	1.77e-05	0.000479	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CA2—glaucoma	1.76e-05	0.000475	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NGFR—glaucoma	1.73e-05	0.000467	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.72e-05	0.000464	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.72e-05	0.000464	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NGF—glaucoma	1.69e-05	0.000457	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HDAC9—glaucoma	1.65e-05	0.000446	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NTRK1—glaucoma	1.64e-05	0.000443	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—C3—glaucoma	1.61e-05	0.000434	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NOS3—glaucoma	1.6e-05	0.000432	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CA1—glaucoma	1.56e-05	0.000422	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NR3C1—glaucoma	1.55e-05	0.00042	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CTSA—glaucoma	1.51e-05	0.000409	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CDKN2B—glaucoma	1.51e-05	0.000409	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—APOE—glaucoma	1.5e-05	0.000404	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CAV1—glaucoma	1.48e-05	0.0004	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTGS2—glaucoma	1.46e-05	0.000395	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EDN1—glaucoma	1.45e-05	0.000392	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CA2—glaucoma	1.43e-05	0.000386	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—FN1—glaucoma	1.41e-05	0.000381	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.4e-05	0.000378	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.4e-05	0.000378	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—BAD—glaucoma	1.39e-05	0.000377	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CDKN1B—glaucoma	1.39e-05	0.000375	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—CDKN2B—glaucoma	1.36e-05	0.000369	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—CDKN2B—glaucoma	1.34e-05	0.000363	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—NOS3—glaucoma	1.34e-05	0.000362	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NGF—glaucoma	1.33e-05	0.00036	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SMO—glaucoma	1.29e-05	0.000349	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—C3—glaucoma	1.27e-05	0.000342	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TXN—glaucoma	1.24e-05	0.000334	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—glaucoma	1.23e-05	0.000331	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NR3C1—glaucoma	1.2e-05	0.000324	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NTRK2—glaucoma	1.18e-05	0.000319	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—APOE—glaucoma	1.18e-05	0.000319	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CAV1—glaucoma	1.17e-05	0.000316	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.13e-05	0.000305	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NOS3—glaucoma	1.12e-05	0.000303	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.12e-05	0.000302	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FN1—glaucoma	1.11e-05	0.000301	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—BAD—glaucoma	1.1e-05	0.000297	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CA1—glaucoma	1.03e-05	0.000279	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NGFR—glaucoma	1.01e-05	0.000274	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TXN—glaucoma	1.01e-05	0.000272	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CTSA—glaucoma	9.98e-06	0.00027	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CDKN1B—glaucoma	9.71e-06	0.000262	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NTRK1—glaucoma	9.63e-06	0.00026	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTT1—glaucoma	9.6e-06	0.000259	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CA2—glaucoma	9.43e-06	0.000255	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.19e-06	0.000248	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.11e-06	0.000246	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP9—glaucoma	8.99e-06	0.000243	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDKN2B—glaucoma	8.87e-06	0.00024	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOS3—glaucoma	8.84e-06	0.000239	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EDN1—glaucoma	8.51e-06	0.00023	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—glaucoma	8.07e-06	0.000218	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NGF—glaucoma	7.82e-06	0.000211	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTT1—glaucoma	7.81e-06	0.000211	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.74e-06	0.000209	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CDKN1B—glaucoma	7.66e-06	0.000207	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ABCA1—glaucoma	7.65e-06	0.000207	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP1B1—glaucoma	7.65e-06	0.000207	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—C3—glaucoma	7.44e-06	0.000201	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP9—glaucoma	7.09e-06	0.000192	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOE—glaucoma	6.92e-06	0.000187	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CAV1—glaucoma	6.86e-06	0.000185	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TXN—glaucoma	6.64e-06	0.00018	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FN1—glaucoma	6.53e-06	0.000176	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—BAD—glaucoma	6.45e-06	0.000174	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—glaucoma	6.37e-06	0.000172	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.3e-06	0.00017	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ABCA1—glaucoma	6.22e-06	0.000168	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP1B1—glaucoma	6.22e-06	0.000168	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTM1—glaucoma	6.11e-06	0.000165	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—glaucoma	6.1e-06	0.000165	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MTHFR—glaucoma	5.4e-06	0.000146	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOS3—glaucoma	5.19e-06	0.00014	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTT1—glaucoma	5.15e-06	0.000139	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOE—glaucoma	5.03e-06	0.000136	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CAV1—glaucoma	4.98e-06	0.000135	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTM1—glaucoma	4.97e-06	0.000134	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—glaucoma	4.81e-06	0.00013	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDKN1B—glaucoma	4.49e-06	0.000121	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MTHFR—glaucoma	4.4e-06	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP9—glaucoma	4.16e-06	0.000112	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCA1—glaucoma	4.1e-06	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP1B1—glaucoma	4.1e-06	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOE—glaucoma	4.09e-06	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CAV1—glaucoma	4.06e-06	0.00011	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NOS3—glaucoma	3.77e-06	0.000102	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—glaucoma	3.74e-06	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—glaucoma	3.45e-06	9.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTM1—glaucoma	3.28e-06	8.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NOS3—glaucoma	3.07e-06	8.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MTHFR—glaucoma	2.9e-06	7.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—glaucoma	2.82e-06	7.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—glaucoma	2.8e-06	7.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOE—glaucoma	2.7e-06	7.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CAV1—glaucoma	2.67e-06	7.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NOS3—glaucoma	2.02e-06	5.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—glaucoma	1.85e-06	5e-05	CbGpPWpGaD
